Efficacy and safety of telitacicept in IgA nephropathy: a real-world study
{{output}}
Background: IgA nephropathy (IgAN) is the most common primary glomerular disease in the world, and specific therapeutic methods for IgAN are limited. Telitacicept is a humanized fusion protein composed of a transmembrane activato... ...
